Vivo Bio Tech specializes in preclinical studies for vaccine development, offering a comprehensive range of services that are crucial for advancing vaccine candidates. The approach includes conducting in-vivo studies using live animal models to assess both safety and efficacy, allowing for a better understanding of immune responses within a complex biological system. Vivo Bio Tech focus on immunogenicity testing to evaluate how effectively the vaccine stimulates the immune system, and perform safety and toxicology assessments to identify any potential side effects and establish safe dosage levels before human trials. Pharmacokinetic studies are also conducted to analyze how the vaccine is absorbed, distributed, metabolized, and excreted in the body. Vivo Bio Tech further employs challenge models to test the vaccine’s protective effects by exposing vaccinated animals to the pathogen, thereby assessing efficacy. Overall, Vivo Bio Tech aims to streamline the preclinical process, delivering critical data that facilitates the transition to clinical trials and enhances the efficiency of vaccine development